Strong HIV-specific CD4+ and CD8+ T-lymphocyte proliferative responses in healthy individuals immunized with an HIV-1 DNA vaccine and boosted with recombinant modified vaccinia virus ankara expressing HIV-1 genes.
We investigated HIV-1 vaccine-induced lymphoproliferative responses in healthy volunteers immunized intradermally or intramuscularly (with or without adjuvant granulocyte-macrophage colony-stimulating factor [GM-CSF] protein) with DNA expressing HIV-1 gag, env, rev, and rt at months 0, 1, and 3 using a Biojector and boosted at 9 months with modified vaccinia virus Ankara (MVA) expressing heterologous HIV-1 gag, env, and pol (HIV-MVA). Lymphoproliferative responses to aldrithiol-2 (AT-2)-inactivated-HIV-1 antigen were tested by a [(3)H]thymidine uptake assay and a flow-cytometric assay of specific cell-mediated immune response in activated whole blood (FASCIA-WB) 2 weeks after the HIV-MVA boost (n = 38). A FASCIA using peripheral blood mononuclear cells (FASCIA-PBMC) was also employed (n = 14). Thirty-five of 38 (92%) vaccinees were reactive by the [(3)H]thymidine uptake assay. Thirty-two of 38 (84%) vaccinees were reactive by the CD4(+) T-cell FASCIA-WB, and 7 of 38 (18%) also exhibited CD8(+) T-cell responses. There was strong correlation between the proliferative responses measured by the [(3)H]thymidine uptake assay and CD4(+) T-cell FASCIA-WB (r = 0.68; P < 0.01). Fourteen vaccinees were analyzed using all three assays. Ten of 14 (71%) and 11/14 (79%) demonstrated CD4(+) T-cell responses in FASCIA-WB and FASCIA-PBMC, respectively. CD8(+) T-cell reactivity was observed in 3/14 (21%) and 7/14 (50%) using the FASCIA-WB and FASCIA-PBMC, respectively. All 14 were reactive by the [(3)H]thymidine uptake assay. The overall HIV-specific T-cell proliferative response in the vaccinees employing any of the assays was 100% (38/38). A standardized FASCIA-PBMC, which allows simultaneous phenotyping, may be an option to the [(3)H]thymidine uptake assay for assessment of vaccine-induced T-cell proliferation, especially in isotope-restricted settings.
Aboud
Said
S
Swedish Institute for Infectious Disease Control, SE-171 82 Solna, Sweden.
Nilsson
Charlotta
C
Karlén
Katarina
K
Marovich
Mary
M
Wahren
Britta
B
Sandström
Eric
E
Gaines
Hans
H
Biberfeld
Gunnel
G
Godoy-Ramirez
Karina
K
D016915:AIDS Vaccines / Q000276:immunology* / Q000494:pharmacology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D049109:Cell Proliferation / Q000187:drug effects*; D004279:DNA, Viral / Q000008:administration & dosage; D005434:Flow Cytometry; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage; D015497:HIV-1 / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007114:Immunization / Q000379:methods*; D014616:Vaccinia virus / Q000235:genetics
D016915:AIDS Vaccines; D004279:DNA, Viral; D016178:Granulocyte-Macrophage Colony-Stimulating Factor
Immunol Cell Biol. 1999 Dec;77(6):509-15
10571671
J Immunol. 2008 May 1;180(9):5907-15
18424710
Tumour Biol. 1998;19(3):196-204
9591046
Curr Protoc Immunol. 2001 May;Chapter 7:7.10.1-7.10.10
18432824
J Virol. 1998 Oct;72(10):7992-8001
9733838
J Infect Dis. 2008 Nov 15;198(10):1482-90
18808335
AIDS Res Hum Retroviruses. 2007 Apr;23(4):532-42
17506610
Immunol Cell Biol. 1999 Dec;77(6):559-64
10571678
J Immunol Methods. 1997 Oct 13;208(1):49-59
9433460
AIDS Res Hum Retroviruses. 1998 Jun;14 Suppl 2:S161-6
9672234
AIDS. 2008 Mar 30;22(6):727-35
18356602
Eur J Immunol. 1991 Jun;21(6):1345-9
1845391
Curr Opin HIV AIDS. 2008 May;3(3):349-55
19372989
AIDS. 1990;4 Suppl 1:S201-6
2152568
J Virol. 1987 Jun;61(6):2017-23
3033328
Clin Exp Immunol. 1979 Sep;37(3):551-7
315848
J Virol. 2007 Jan;81(1):434-8
17050606
J Exp Med. 2008 Jan 21;205(1):63-77
18195071
J Immunol Methods. 1996 Sep 9;195(1-2):63-72
8814321
Eur J Immunol. 1994 Jan;24(1):34-40
8020568
J Virol. 2006 May;80(10):4717-28
16641265
J Immunol Methods. 2003 Jun 1;277(1-2):17-25
12799036
Nat Immunol. 2002 Nov;3(11):1061-8
12368910
Science. 1997 Nov 21;278(5342):1447-50
9367954
J Immunol. 2006 Nov 15;177(10):7406-15
17082660